• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MUC1 的过表达通过激活 Akt 和细胞外信号调节激酶途径增强非小细胞肺癌细胞的促血管生成活性。

Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.

机构信息

Department of Severe Respiratory, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Lung. 2011 Dec;189(6):453-60. doi: 10.1007/s00408-011-9327-y. Epub 2011 Oct 1.

DOI:10.1007/s00408-011-9327-y
PMID:21959954
Abstract

BACKGROUND

Angiogenesis is an important process required for tumor progression. Mucin 1 (MUC1) is a transmembrane glycoprotein that is aberrantly upregulated in many types of cancer, including non-small-cell lung cancer (NSCLC). However, the biological significance of MUC1 overexpression in lung cancer angiogenesis is not completely understood.

METHODS

We showed that enforced expression of MUC1 in two NSCLC cell lines, A549 and NCI-H460, which have a low level of endogenous MUC1, promoted their ability to induce vascular endothelial growth factor (VEGF)-dependent endothelial cell migration and tube formation.

RESULTS

There was a significant increase in VEGF expression in MUC1-overexpressing NSCLC cells. Moreover, MUC1 overexpression resulted in a marked elevation in phosphorylated Akt and extracellular signal-regulated kinase (ERK)1/2, indicative of activation of both signaling pathways. Most importantly, inhibition of Akt or ERK signaling using specific chemical inhibitors restrained the proangiogenic activity of MUC1-overexpressing NSCLC cells.

CONCLUSIONS

Taken together, our present data demonstrate that the aberrant upregulation of MUC1 favors tumor angiogenesis in NSCLC, likely through the activation of both Akt and ERK pathways and elevation of VEGF production. MUC1 may thus be a potential antiangiogenic target in NSCLC.

摘要

背景

血管生成是肿瘤进展所必需的重要过程。黏蛋白 1(MUC1)是一种跨膜糖蛋白,在许多类型的癌症中异常上调,包括非小细胞肺癌(NSCLC)。然而,MUC1 在肺癌血管生成中的过度表达的生物学意义尚不完全清楚。

方法

我们表明,在两种 NSCLC 细胞系 A549 和 NCI-H460 中强制表达 MUC1,这两种细胞系内源性 MUC1 水平较低,促进了它们诱导血管内皮生长因子(VEGF)依赖性内皮细胞迁移和管状形成的能力。

结果

在过表达 MUC1 的 NSCLC 细胞中,VEGF 表达显著增加。此外,MUC1 的过表达导致磷酸化 Akt 和细胞外信号调节激酶(ERK)1/2 的明显升高,表明两条信号通路均被激活。最重要的是,使用特异性化学抑制剂抑制 Akt 或 ERK 信号通路可限制过表达 MUC1 的 NSCLC 细胞的促血管生成活性。

结论

综上所述,我们目前的数据表明,MUC1 的异常上调有利于 NSCLC 的肿瘤血管生成,可能通过激活 Akt 和 ERK 通路以及升高 VEGF 的产生。因此,MUC1 可能是 NSCLC 中的一种潜在的抗血管生成靶点。

相似文献

1
Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.MUC1 的过表达通过激活 Akt 和细胞外信号调节激酶途径增强非小细胞肺癌细胞的促血管生成活性。
Lung. 2011 Dec;189(6):453-60. doi: 10.1007/s00408-011-9327-y. Epub 2011 Oct 1.
2
Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.转移相关蛋白 2 通过调节 ERK/AKT 和 VEGF 信号通路促进非小细胞肺癌的转移。
Mol Med Rep. 2018 Apr;17(4):4899-4908. doi: 10.3892/mmr.2018.8535. Epub 2018 Feb 1.
3
Nickel-induced VEGF expression via regulation of Akt, ERK1/2, NFκB, and AMPK pathways in H460 cells.镍通过调节 Akt、ERK1/2、NFκB 和 AMPK 通路诱导 H460 细胞中 VEGF 的表达。
Environ Toxicol. 2019 May;34(5):652-658. doi: 10.1002/tox.22731. Epub 2019 Feb 6.
4
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.微小RNA-135a通过IGF-1/PI3K/Akt信号通路对非小细胞肺癌细胞增殖、迁移、侵袭、凋亡及肿瘤血管生成的影响
Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17.
5
Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.热疗通过AKT和ERK信号通路诱导肺癌中HIF-1α的表达。
J Exp Clin Cancer Res. 2016 Jul 26;35(1):119. doi: 10.1186/s13046-016-0399-7.
6
Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.黏蛋白 1 通过激活 AKT 信号通路增强肿瘤血管生成反应。
Oncogene. 2012 Apr 26;31(17):2187-98. doi: 10.1038/onc.2011.410. Epub 2011 Sep 19.
7
RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.RNAi 介导的 VEGF-C 沉默通过同时下调 CXCR4、CCR7、VEGFR-2 和 VEGFR-3 依赖性轴诱导的 ERK、p38 和 AKT 信号通路抑制非小细胞肺癌的进展。
Eur J Cancer. 2011 Oct;47(15):2353-63. doi: 10.1016/j.ejca.2011.05.006. Epub 2011 Jun 15.
8
Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.细胞色素 P450 ω-羟化酶通过上调非小细胞肺癌中的 VEGF 和 MMP-9 促进血管生成和转移。
Cancer Chemother Pharmacol. 2011 Sep;68(3):619-29. doi: 10.1007/s00280-010-1521-8. Epub 2010 Dec 1.
9
microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.微小RNA-128通过直接靶向血管内皮生长因子-C,在人类非小细胞肺癌的肿瘤发生、血管生成和淋巴管生成中发挥关键作用。
Eur J Cancer. 2014 Sep;50(13):2336-50. doi: 10.1016/j.ejca.2014.06.005. Epub 2014 Jul 4.
10
Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).M2型乙酰胆碱受体/核因子κB信号轴失活可逆转非小细胞肺癌(NSCLC)中的上皮-间质转化(EMT),并抑制其迁移和侵袭。
Oncotarget. 2015 Oct 6;6(30):29335-46. doi: 10.18632/oncotarget.5004.

引用本文的文献

1
The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets.黏蛋白家族在肺癌中的多方面作用:从预后生物标志物到有前景的靶点。
Front Immunol. 2025 Jun 27;16:1608140. doi: 10.3389/fimmu.2025.1608140. eCollection 2025.
2
Transmembrane mucins in lung adenocarcinoma: understanding of current molecular mechanisms and clinical applications.肺腺癌中的跨膜黏蛋白:对当前分子机制及临床应用的认识
Cell Death Discov. 2025 Apr 10;11(1):163. doi: 10.1038/s41420-025-02455-3.
3
The multifaceted role of MUC1 in tumor therapy resistance.

本文引用的文献

1
Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.非小细胞肺癌细胞中对 MUC1-C 癌蛋白的依赖。
Mol Cancer Ther. 2011 May;10(5):806-16. doi: 10.1158/1535-7163.MCT-10-1050. Epub 2011 Mar 18.
2
MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma.MUC1 在胸腺瘤中的表达:MUC1 可能是区分 B3 型胸腺瘤和胸腺癌的有用标志物。
Virchows Arch. 2011 May;458(5):615-20. doi: 10.1007/s00428-011-1041-x. Epub 2011 Jan 21.
3
Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer.
MUC1 在肿瘤治疗耐药中的多效性作用。
Clin Exp Med. 2023 Sep;23(5):1441-1474. doi: 10.1007/s10238-022-00978-y. Epub 2022 Dec 23.
4
EGFR-Dependent Extracellular Matrix Protein Interactions Might Light a Candle in Cell Behavior of Non-Small Cell Lung Cancer.表皮生长因子受体(EGFR)依赖的细胞外基质蛋白相互作用可能为非小细胞肺癌的细胞行为带来一线希望。
Front Oncol. 2021 Dec 15;11:766659. doi: 10.3389/fonc.2021.766659. eCollection 2021.
5
Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling.MUC1与VEGF在血管生成和转移中的相互作用:一篇综述,重点介绍MUC1的作用,着重于转移和血管生成信号传导。
Cancer Cell Int. 2021 Apr 9;21(1):200. doi: 10.1186/s12935-021-01899-8.
6
The role of mucin 1 in respiratory diseases.黏蛋白 1 在呼吸疾病中的作用。
Eur Respir Rev. 2021 Feb 2;30(159). doi: 10.1183/16000617.0149-2020. Print 2021 Mar 31.
7
Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer.全面分析黏蛋白在肺癌中的作用机制及治疗意义。
J Exp Clin Cancer Res. 2020 Aug 17;39(1):162. doi: 10.1186/s13046-020-01662-3.
8
Endomucin inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by modulating VEGFR2 signaling.内皮黏蛋白通过调节 VEGFR2 信号抑制 VEGF 诱导的内皮细胞迁移、生长和形态发生。
Sci Rep. 2017 Dec 7;7(1):17138. doi: 10.1038/s41598-017-16852-x.
9
MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function.MUC1:首个具有抗炎功能的呼吸道黏蛋白。
J Clin Med. 2017 Nov 29;6(12):110. doi: 10.3390/jcm6120110.
10
Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer.跨膜黏蛋白:炎症与癌症交叉点上的信号受体
J Innate Immun. 2017;9(3):281-299. doi: 10.1159/000453594. Epub 2017 Jan 5.
MUC1 在 IB 期非小细胞肺癌中的表达及预后相关性。
Med Oncol. 2011 Dec;28 Suppl 1:S596-604. doi: 10.1007/s12032-010-9752-4. Epub 2010 Nov 30.
4
Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.β-连环蛋白、MUC1 和 c-met 在弥漫型胃癌中的表达:与肿瘤进展和预后的相关性。
Anticancer Res. 2010 Nov;30(11):4635-41.
5
Anti-VEGF therapy in breast and lung mouse models of cancers.癌症的乳腺和肺部小鼠模型中的抗血管内皮生长因子治疗
J Biomed Biotechnol. 2011;2011:947928. doi: 10.1155/2011/947928. Epub 2010 Nov 7.
6
Global patterns of cancer incidence and mortality rates and trends.全球癌症发病率、死亡率的分布格局及变化趋势。
Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907. doi: 10.1158/1055-9965.EPI-10-0437. Epub 2010 Jul 20.
7
RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma.RKTG 通过抑制 MAPK 介导的自分泌 VEGF 信号通路来抑制血管生成,并且在肾透明细胞癌中下调。
Oncogene. 2010 Sep 30;29(39):5404-15. doi: 10.1038/onc.2010.270. Epub 2010 Jul 5.
8
Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer.黏膜和 CD56 作为壶腹周围癌侵袭和预后的标志物。
Br J Surg. 2010 Aug;97(8):1269-78. doi: 10.1002/bjs.7107.
9
Angiogenesis inhibitors: current strategies and future prospects.血管生成抑制剂:当前策略与未来前景。
CA Cancer J Clin. 2010 Jul-Aug;60(4):222-43. doi: 10.3322/caac.20075. Epub 2010 Jun 16.
10
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.黏蛋白1癌蛋白与信号转导和转录激活因子1通路在预后不良的人类乳腺癌中的协同作用。
Oncogene. 2010 Feb 11;29(6):920-9. doi: 10.1038/onc.2009.391. Epub 2009 Nov 16.